Cancer Stem Cell Differentiation
Cancer stem cells (CSCs), also known as tumor initiation cells (TICs), are undifferentiated cancer cells that can self-renew and differentiate into bulk tumor cells. They are thought to have a role in the resistance of tumors to therapy, and for disease recurrence.
Cat. No. | 产品名称/活性 |
---|---|
1803 | ITE |
Induces stem-like cancer cell differentiation; also inhibits TGF-β-induced human myofibroblast differentiation | |
3070 | Thioridazine hydrochloride |
Selective inducer of CSC differentiation; anticancer agent |
Literature for Cancer Stem Cell Differentiation
Tocris offers the following scientific literature for Cancer Stem Cell Differentiation to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Stem Cells Scientific Review
Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.
Stem Cell Workflow Poster
Stem cells have potential as a source of cells and tissues for research and treatment of disease. This poster summarizes some key protocols demonstrating the use of small molecules across the stem cell workflow, from reprogramming, through self-renewal, storage and differentiation to verification. Advantages of using small molecules are also highlighted.